Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | potassium voltage-gated channel, subfamily H (eag-related), member 2 | Starlite/ChEMBL | References |
Homo sapiens | kinase insert domain receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0151 | 0.0143 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.0028 | 0.002 |
Brugia malayi | Fibronectin type III domain containing protein | 0.0011 | 0.002 | 0.0139 |
Schistosoma mansoni | cyclic-nucleotide-gated cation channel | 0.0009 | 0.0009 | 0.043 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0042 | 0.0165 | 1 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0049 | 0.0199 | 1 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.0045 | 0.0179 | 0.0171 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.002 | 0.0012 |
Loa Loa (eye worm) | hypothetical protein | 0.2102 | 1 | 1 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0049 | 0.0199 | 1 |
Schistosoma mansoni | cyclic-nucleotide-gated cation channel | 0.0009 | 0.0009 | 0.043 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0183 | 0.0838 | 0.083 |
Loa Loa (eye worm) | inward rectifying k channel family protein 1 | 0.2102 | 1 | 1 |
Echinococcus granulosus | voltage gated potassium channel | 0.0013 | 0.0028 | 0.1145 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0009 | 0.0009 | 0.043 |
Echinococcus granulosus | twitchin | 0.0014 | 0.0034 | 0.1481 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.002 | 0.0012 |
Toxoplasma gondii | hypothetical protein | 0.2102 | 1 | 0.5 |
Schistosoma mansoni | cell adhesion molecule | 0.0015 | 0.0038 | 0.1893 |
Echinococcus multilocularis | basement membrane specific heparan sulfate | 0.0011 | 0.002 | 0.0678 |
Schistosoma mansoni | vesicular amine transporter | 0.0014 | 0.0034 | 0.1717 |
Schistosoma mansoni | Neurotrimin precursor (hNT) | 0.0011 | 0.002 | 0.1012 |
Echinococcus granulosus | neurotracting:lsamp:neurotrimin:obcam | 0.0015 | 0.0038 | 0.1703 |
Schistosoma mansoni | tyrosine kinase | 0.0008 | 0.0003 | 0.0128 |
Schistosoma mansoni | hyperpolarization activated cyclic nucleotide-gated potassium channel | 0.0009 | 0.0009 | 0.043 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0011 | 0.002 | 0.0139 |
Loa Loa (eye worm) | hypothetical protein | 0.2102 | 1 | 1 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0013 | 0.0028 | 0.1414 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0038 | 0.0029 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0045 | 0.0179 | 1 |
Echinococcus granulosus | Immunoglobulin | 0.0011 | 0.002 | 0.0678 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0051 | 0.0043 |
Echinococcus multilocularis | Immunoglobulin | 0.0011 | 0.002 | 0.0678 |
Schistosoma mansoni | defective proboscis extension response (dpr)-related | 0.0011 | 0.002 | 0.1012 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0183 | 0.0838 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.002 | 0.0012 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0013 | 0.0028 | 0.1145 |
Echinococcus granulosus | roundabout 2 | 0.0018 | 0.0051 | 0.2506 |
Schistosoma mansoni | hyperpolarization activated cyclic nucleotide-gated potassium channel | 0.0009 | 0.0009 | 0.043 |
Echinococcus multilocularis | Immunoglobulin | 0.0011 | 0.002 | 0.0678 |
Echinococcus multilocularis | neuroglian | 0.0014 | 0.0034 | 0.1481 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0045 | 0.0179 | 1 |
Brugia malayi | Voltage-gated potassium channel, EAG (KCNH1)-related. C. elegans egl-2 ortholog | 0.0013 | 0.0028 | 0.0235 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.002 | 0.0012 |
Echinococcus multilocularis | roundabout 2 | 0.0018 | 0.0051 | 0.2506 |
Brugia malayi | hypothetical protein | 0.0011 | 0.002 | 0.0139 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.002 | 0.0012 |
Echinococcus multilocularis | voltage gated potassium channel | 0.0013 | 0.0028 | 0.1145 |
Schistosoma mansoni | cyclic-nucleotide-gated cation channel | 0.0009 | 0.0009 | 0.043 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0013 | 0.0028 | 0.1414 |
Brugia malayi | Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog | 0.0045 | 0.0179 | 0.2056 |
Schistosoma mansoni | nephrin | 0.0014 | 0.0034 | 0.1702 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0042 | 0.0165 | 1 |
Echinococcus granulosus | defective proboscis extension response | 0.0011 | 0.002 | 0.0678 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.002 | 0.0012 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0013 | 0.0028 | 0.1145 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0051 | 0.0043 |
Onchocerca volvulus | Tyrosine kinase homolog | 0.0171 | 0.0781 | 1 |
Echinococcus granulosus | neuroglian | 0.0014 | 0.0034 | 0.1481 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 5 nM | Inhibition of human KDR kinase by HTRF assay | ChEMBL. | 17425296 |
IC50 (binding) | = 5 nM | Inhibition of human KDR kinase by HTRF assay | ChEMBL. | 17425296 |
IC50 (functional) | = 58 nM | Inhibition of VEGF-induced phosphorylation of human KDR expressed in mouse NIH3T3 cell line by Western blot | ChEMBL. | 17425296 |
IC50 (functional) | = 58 nM | Inhibition of VEGF-induced phosphorylation of human KDR expressed in mouse NIH3T3 cell line by Western blot | ChEMBL. | 17425296 |
IC50 (binding) | = 5.87 uM | Displacement of [3H]dofetilide from hERG expressed in HEK293 cells | ChEMBL. | 17425296 |
IC50 (binding) | = 5.87 uM | Displacement of [3H]dofetilide from hERG expressed in HEK293 cells | ChEMBL. | 17425296 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.